Development of Polymeric Nanoparticles of Garcinia mangostana Xanthones in Eudragit RL100/RS100 for Anti-Colon Cancer Drug Delivery

Journal of Nanomaterials

Volumn 2015, Issue , 2015, Pages

  Aisha, Abdalrahim F A ^a   Abdulmajid, Amin Malik Shah ^a   Ismail, Zhari ^a   Alrokayan, Salman A ^b   Abu Salah, Khalid M ^b,c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DISEASES; DYNAMIC LIGHT SCATTERING; ELECTRON MICROSCOPY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIGHT SCATTERING; MOLECULAR BIOLOGY; PARTICLE SIZE; POLYMERS; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; TRANSMISSION ELECTRON MICROSCOPY;

CATIONIC NANOPARTICLES; INHIBITORY CONCENTRATION; INTERMOLECULAR INTERACTIONS; NANOPARTICLE SOLUTIONS; NANOPRECIPITATION METHOD; ORAL DRUG DELIVERY SYSTEM; POLYMERIC NANOPARTICLES; THERAPEUTIC APPLICATION;

NANOPARTICLES;

EID: 84950148705     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2015/701979     Document Type: Article

References (33)

1. Y. Akao, Y. Nakagawa, M. Iinuma, and Y. Nozawa, "Anti-cancer effects of xanthones from pericarps of mangosteen, " International Journal of Molecular Sciences, vol. 9, no. 3, pp. 355-370, 2008.
2. J. Pedraza-Chaverri, N. Cárdenas-Rodríguez, M. Orozco-Ibarra, and J. M. Pérez-Rojas, "Medicinal properties of mangosteen (Garciniamangostana), " Food and Chemical Toxicology, vol. 46, no. 10, pp. 3227-3239, 2008.
3. D. Obolskiy, I. Pischel, N. Siriwatanametanon, and M. Heinrich, "Garcinia mangostana L. : a phytochemical and pharmacological review, " Phytotherapy Research, vol. 23, no. 8, pp. 1047-1065, 2009.
4. K. Matsumoto, Y. Akao, H. Yi et al. , "Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells, " Bioorganic and Medicinal Chemistry, vol. 12, no. 22, pp. 5799-5806, 2004.
5. H. Doi, M.-A. Shibata, E. Shibata et al. , "Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer, " Anticancer Research, vol. 29, no. 7, pp. 2485-2495, 2009.
6. S.-H. Hung, K.-H. Shen, C.-H. Wu, C.-L. Liu, and Y.-W. Shih, " α-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway, " Journal of Agricultural and Food Chemistry, vol. 57, no. 4, pp. 1291-1298, 2009.
7. J.-H. Yoo, K. Kang, E. H. Jho, Y.-W. Chin, J. Kim, and C. W. Nho, " α-and γ-Mangostin inhibit the proliferation of colon cancer cells via beta;-catenin gene regulation in Wnt/cGMP signalling, " Food Chemistry, vol. 129, no. 4, pp. 1559-1566, 2011.
8. S. Tewtrakul, C. Wattanapiromsakul, and W. Mahabusarakam, "Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264. 7 macrophage cells, " Journal of Ethnopharmacology, vol. 121, no. 3, pp. 379-382, 2009.
9. L.-G. Chen, L.-L. Yang, and C.-C. Wang, "Anti-inflammatory activity of mangostins from Garcinia mangostana, " Food and Chemical Toxicology, vol. 46, no. 2, pp. 688-693, 2008.
10. Y. Sakagami, M. Iinuma, K. G. N. P. Piyasena, and H. R. W. Dharmaratne, "Antibacterial activity of α-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics, " Phytomedicine, vol. 12, no. 3, pp. 203-208, 2005.
11. S. Suksamrarn, N. Suwannapoch, W. Phakhodee et al. , "Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana, " Chemical and Pharmaceutical Bulletin, vol. 51, no. 7, pp. 857-859, 2003.
12. P. D. Sampath and K. Vijayaraghavan, "Cardioprotective effect of α-mangostin, a xanthone derivative from Mangosteen on tissue defense system against isoproterenol-inducedmyocardial infarction in rats, " Journal of Biochemical and Molecular Toxicology, vol. 21, no. 6, pp. 336-339, 2007.
13. J. Cui, W. Hu, Z. Cai et al. , "New medicinal properties of mangostins: analgesic activity and pharmacological characterization of active ingredients fromthe fruit hull of Garcinia mangostana L. , " Pharmacology Biochemistry and Behavior, vol. 95, no. 2, pp. 166-172, 2010.
14. H.-A. Jung, B.-N. Su, W. J. Keller, R. G. Mehta, and A. D. Kinghorn, "Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen), " Journal of Agricultural and Food Chemistry, vol. 54, no. 6, pp. 2077-2082, 2006.
15. Y.-P. Tang, P.-G. Li, M. Kondo, H.-P. Ji, Y. Kou, and B. Ou, "Effect of amangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial, " Journal of Medicinal Food, vol. 12, no. 4, pp. 755-763, 2009.
16. L. Yu, M. Zhao, B. Yang, and W. Bai, "Immunomodulatory and anticancer activities of phenolics from Garcinia mangostana fruit pericarp, " Food Chemistry, vol. 116, no. 4, pp. 969-973, 2009.
17. A. F. A. Aisha, K. M. Abu-Salah, Z. Ismail, and A. Majid, "In vitro and in vivo anti-colon cancer effects of Garcinia mangostana xanthones extract, " BMC Complementary and Alternative Medicine, vol. 12, article 104, 2012.
18. L. Li, I. Brunner, A.-R. Han et al. , "Pharmacokinetics of alphamangostin in rats after intravenous andoral application, " MolecularNutrition and Food Research, vol. 55, supplement 1, pp. S67-S74, 2011.
19. N. Ubrich, C. Schmidt, R. Bodmeier, M. Hoffman, and P. Maincent, "Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles, " International Journal of Pharmaceutics, vol. 288, no. 1, pp. 169-175, 2005.
20. A. Lopedota, A. Trapani, A. Cutrignelli et al. , "The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione, " European Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 3, pp. 509-520, 2009.
21. R. Pignatello, C. Bucolo, P. Ferrara, A. Maltese, A. Puleo, and G. Puglisi, "Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen, " European Journal of Pharmaceutical Sciences, vol. 16, no. 1-2, pp. 53-61, 2002.
22. X. Dong, C. A. Mattingly, M. T. Tseng et al. , "Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcomemultidrug resistance by inhibiting P-glycoprotein and depleting ATP, " Cancer Research, vol. 69, no. 9, pp. 3918-3926, 2009.
23. OECD, OECD 105 Guidelines for the Testing of Chemicals, Water Solubility, Organization for Economic Cooperation & Development, Paris, France, 1995.
24. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, "Nanocapsule formation by interfacial polymer deposition following solvent displacement, " International Journal of Pharmaceutics, vol. 55, no. 1, pp. R1-R4, 1989.
25. M. Sameti, G. Bohr, M. N. V. Ravi Kumar et al. , "Stabilisation by freeze-drying of cationicallymodified silica nanoparticles for gene delivery, " International Journal of Pharmaceutics, vol. 266, no. 1-2, pp. 51-60, 2003.
26. E. L. McConnell, H. M. Fadda, and A. W. Basit, "Gut instincts: explorations in intestinal physiology and drug delivery, " International Journal of Pharmaceutics, vol. 364, no. 2, pp. 213-226, 2008.
27. A. Rajput, I. Dominguez SanMartin, R. Rose et al. , "Characterization of HCT116 human colon cancer cells in an orthotopic model, " Journal of Surgical Research, vol. 147, no. 2, pp. 276-281, 2008.
28. A. F. A. Aisha, Z. Ismail, K. M. Abu-salah, and A. M. S. A. Majid, "Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles, " Journal of Pharmaceutical Sciences, vol. 101, no. 2, pp. 815-825, 2012.
29. L. M. Jost, J. M. Kirkwood, and T. L. Whiteside, "Improved short-and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells, " Journal of Immunological Methods, vol. 147, no. 2, pp. 153-165, 1992.
30. U. Bilati, E. Allémann, and E. Doelker, "Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles, " European Journal of Pharmaceutical Sciences, vol. 24, no. 1, pp. 67-75, 2005.
31. S. De Chasteigner, G. Cavé, H. Fessi, J.-P. Devissaguet, and F. Puisieux, "Freeze-drying of itraconazole-loaded nanosphere suspensions: a feasibility study, " Drug Development Research, vol. 38, no. 2, pp. 116-124, 1996.
32. H. Lee, C.-H. Ahn, and T. G. Park, "Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin, " Macromolecular Bioscience, vol. 9, no. 4, pp. 336-342, 2009.
33. K. T. Thurn, H. Arora, T. Paunesku et al. , "Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 7, no. 2, pp. 123-130, 2011.